Antihypertensive Drugs Market Analysis

1
Global Antihypertensive Drugs Market Growth to be
Propelled by a Surge in the Incidence of
Hypertension at a CAGR of Approximately 3
During 2022-2031 Kenneth Research published a
report titled Antihypertensive Drugs Market
Global Supply Demand Analysis Opportunity
Outlook 2031 which delivers a detailed overview
of the global antihypertensive drugs market in
terms of market segmentation by drug class, by
distribution channel, and by region. Further, for
the in-depth analysis, the report encompasses the
industry growth indicators, restraints, supply
and demand risk, along with detailed discussion
on current and future market trends that are
associated with the growth of the market.
The global antihypertensive drugs market is
estimated to gain a remarkable revenue of around
USD 40 billion by growing steadily at a CAGR of
about 3 over the forecast period, i.e., 2022
2031. The growth of the market can be attributed
to an increase in the number of cases of
hypertension across the world. The World Health
Organization
2
(WHO) states that around 1.28 billion adults have
hypertension, with almost two- thirds of them
living in low- and middle-income countries. An
expanding geriatric population and high salt
intake are also projected to create a greater
demand for Antihypertensive drugs. Moreover, an
increased awareness about complications related
to hypertension is predicted to propel the growth
of the market over the forecast
period. For Detailed Description https//www.kenne
thresearch.com/report- details/antihypertensive-d
rugs-market/10082827 The global antihypertensive
drugs market is segmented and analyzed for demand
and supply by drug class into calcium channel
blockers, ACE inhibitors, adrenergic blockers,
angiotensin II receptor blockers, diuretics,
vasodilators, and others. The ACE inhibitors
segment is expected to display faster growth over
the forecast period owing to its use in lowering
blood pressure as well as in treating other
diseases like diabetes and chronic kidney
diseases. Geographically, the global
antihypertensive drugs market is segmented into
five major regions including North America,
Europe, Asia Pacific, Latin America, and the
Middle East Africa. The market in the North
American region has witnessed notable growth
because of the easy availability of
antihypertensive drugs, a rise in the geriatric
population, and the widespread occurrence of
hypertension among its people. However,
Asia-Pacific is projected to record the highest
growth in the market share during the forecast
period, owing to a spike in awareness related to
hypertension and the use of antihypertensive
drugs. The research is global in nature and
covers detailed analysis on the market in North
America (U.S., Canada), Europe (U.K., Germany,
France, Italy, Spain, Hungary, Belgium,
Netherlands Luxembourg, NORDIC Finland,
Sweden, Norway, Denmark, Poland, Turkey,
Russia, Rest of Europe), Latin America (Brazil,
Mexico, Argentina, Rest of Latin America),
Asia-Pacific (China, India, Japan, South Korea,
Indonesia, Singapore, Malaysia, Australia, New
Zealand, Rest of Asia-Pacific), Middle East and
Africa (Israel,
3
GCC Saudi Arabia, UAE, Bahrain, Kuwait, Qatar,
Oman, North Africa, South Africa, Rest of
Middle East and Africa). In addition, analysis
comprising market size, Y-O-Y growth
opportunity analysis, market players competitive
study, investment opportunities, demand for
future outlook etc. has also been covered and
displayed in the research report. Rise in the
Number of Cardiovascular Diseases to Drive Market
Growth CVDs are the leading cause of death
globally with an estimated 17.9 million died in
the year 2019, as per the data collected by the
World Health Organization (WHO). High blood
pressure is at the root of many cardiovascular
diseases (CVDs) like coronary heart disease,
cerebrovascular disease, rheumatic heart disease,
and others. Hence, the rising number of cases of
cardiovascular disorders is projected to prompt
an increase in the growth of the global
antihypertensive drugs market. However,
expiration of patents leading to an increase in
cheaper copies of original drugs in the market,
strict regulations for the approval of new drugs,
and lack of awareness among the people related
to hypertension symptoms are expected to operate
as key restraints to the growth of global
antihypertensive drugs market over the forecast
period. This report also provides the existing
competitive scenario of some of the key players
in the global antihypertensive drugs market
which includes company profiling of AstraZeneca,
Boehringer Ingelheim International GmbH, Johnson
Johnson Services, Inc., Merck KGaA, Bayer AG,
Lupin Limited, Daiichi Sankyo Company, Limited,
GlaxoSmithKline plc, Medtronic, and others. The
profiling enfolds key information of the
companies which encompasses business overview,
products and services, key financials and recent
news and developments. On the whole, the report
depicts detailed overview of the global
antihypertensive drugs market that will help
industry consultants, equipment manufacturers,
existing players searching for expansion
opportunities, new players searching
possibilities and other stakeholders to align
their market centric strategies according to the
ongoing and expected trends in the future.
4
Request Report Sample_at_ https//www.kennethresearch
.com/sample-request- 10082827 Research Nester is
a leading service provider for strategic market
research and consulting. We aim to provide
unbiased, unparalleled market insights and
industry analysis to help industries,
conglomerates and executives to take wise
decisions for their future marketing strategy,
expansion and investment etc. We believe every
business can expand to its new horizon, provided
a right guidance at a right time is available
through strategic minds. Our out of box thinking
helps our clients to take wise decision in order
to avoid future uncertainties. Contact for more
Info AJ Daniel Email sales_at_kennethresearch.com
U.S. Phone [phone]